Colossal Biosciences
Sam Singer is the CFO of Colossal Bioscience with extensive experience as a finance executive and investor in the biotech industry. Before joining Colossal, Sam was the Chief Financial Officer of Totus Medicines, a small molecule oncology focused biotechnology company where he was primarily responsible for growing the finance group, investor outreach and strategic messaging, including financial planning. Prior to Totus, Sam was an investor in the biotech sector leading analysis and valuation with a focus on gene editing companies.
This person is not in any offices
Colossal Biosciences
4 followers
At Colossal Biosciences, we endeavor to jumpstart nature’s ancestral heartbeat. To see the woolly mammoth thunder upon the tundra once again. To advance the economics of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet can breathe easier. These things, which were not achievable before, are now. In our laboratories. Through our breakthroughs in CRISPR and genetic engineering. We are leading the new charge of bioscience. We accept the responsibility. And we can see the light at the end of it all.